Clin2
NCT06541574Possibly a fitRecruiting

Preventing scar tissue after retinal detachment surgery

Proliferative VitreoretinopathyRhegmatogenous Retinal Detachment

Treatments studied

Part of Eyes & vision clinical trials.

This trial tests if injecting a medication called methotrexate into the eye during retinal detachment surgery can prevent scar tissue from forming. Scar tissue can sometimes cause the retina to detach again, so this treatment might lower that risk.

Summary written for real people, not researchers, by Clin2.

Phase
Phase 2
Enrollment
860 people
Ages
18 years and older
Study type
Interventional

Who can take part

  • You are 18 years or older
  • You are having surgery to repair a retinal detachment for the first time
  • Your retinal detachment symptoms started less than 6 weeks ago
  • You are not pregnant, breastfeeding, or planning to become pregnant
  • You have not had certain previous eye problems like severe trauma or infection
  • You do not have an allergy or intolerance to methotrexate

View the official record on ClinicalTrials.gov

Quick eligibility check

Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.

Similar studies

Other trials that look related to this one.

NCT06818721Not yet recruiting· Phase 2
Eye injection of topotecan for retinal detachment scar prevention

This trial tests a shot of topotecan into the eye during retinal detachment surgery to try to prevent or treat a scar-like condition called proliferative vitreoretinopathy that can cause vision loss. It is for adults who are already having surgery for a retinal tear.

Toronto, Ontario
NCT05331664Recruiting· Phase 4
Dropless vitrectomy eye drops for retinal detachment surgery

This trial studies a “dropless” method (fewer post-surgery eye drops) after pars plana vitrectomy, a surgery used to repair a retinal detachment. It may help by improving comfort and simplifying recovery for people having this specific type of retinal detachment repair.

Boston, Massachusetts
NCT06425419Not yet recruiting· Phase 1
Eye injection of topotecan for retinal scarring after detachment

This trial tests a medication called topotecan, which is injected into the eye during surgery to treat a serious scarring condition called proliferative vitreoretinopathy (PVR). It may help prevent the retina from detaching again after surgery for retinal detachment or eye injury.

NCT07386678Not yet recruiting
Imaging and biomarkers in uncomplicated retinal detachment

This study uses imaging and molecular tests to better understand uncomplicated retinal detachment. It may help identify new ways to diagnose or manage this condition.

London
NCT05538156Not yet recruiting
Peeling a retina layer during retinal detachment surgery

This study looks at a specific surgical technique—peeling a thin retina layer—during surgery for a type of retinal detachment. It may help improve how well vision recovers when the detachment affects the macula and is more complex.

NCT06997874Recruiting· Phase 3
Surgery Comparison for Retinal Detachment Without Prior Cataract Surgery

This trial compares two types of surgery for people with a retinal detachment who still have their natural lens (no prior cataract surgery). One group gets vitrectomy alone; the other gets vitrectomy plus the lens removed at the same time. The goal is to see which approach leads to better outcomes.

Aylesbury

Hear when a new Proliferative Vitreoretinopathy trial opens

We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.